Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025)
Protagonist Therapeutics (PTGX) reported Current Taxes of $1.9 million for Q1 2025, down 43.21% on a YoY basis from $3.3 million in Q1 2024, and down 29.75% sequentially from $2.7 million in Q4 2024.
Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025) Analysis & Trends
Protagonist Therapeutics (PTGX) has 3 years of Current Taxes data on file, last reported at $1.9 million in Q1 2025.
- For the quarter ending Q1 2025, Current Taxes fell 43.21% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2025 stood at $1.9 million (down 43.21% YoY), and the FY2024 full-year result was $2.7 million, changed N/A from the prior year.
- Current Taxes slipped to $1.9 million in Q1 2025, from $2.7 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $3.3 million in Q1 2024 to a low of $1.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Protagonist Therapeutics | 8.81 Bn | 8.81 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 3.33 Mn |
| Jun 30, 2018 | 276,000.00 |
| Mar 31, 2018 | 379,000.00 |